When does WELL.TO report earnings and what matters most

WELL.TO reports earnings on 19 Mar 2026. Investors should focus on revenue growth, adjusted EBITDA margins, WELLSTAR progress, and commentary on cash flow and integration of recent billing acquisitions.

What is Meyka AI’s rating for WELL.TO stock

Meyka AI rates WELL.TO with a score of **68.07** out of 100, graded **B** with a **HOLD** suggestion. The grade factors in benchmark and sector comparison, growth, key metrics, forecasts, and analyst consensus.

What price targets and forecast exist for WELL.TO stock

Meyka AI's one-year forecast is **C$4.27**, matching the current price of **C$4.27**. We model a conservative target **C$3.50** and a bullish target **C$6.00**. Forecasts are projections and not guarantees.

What are the main risks for WELL Health (WELL.TO)

Main risks include weak cash flow conversion, elevated net-debt-to-EBITDA, execution risk on the WELLSTAR spin-out, regulatory changes in healthcare, and integration of recent acquisitions.

CA Stocks

Closed C$4.27: WELL.TO WELL Health (TSX) 17 Mar 2026 earnings catalysts

ByHuzaifa Zahoor March 18, 2026March 18, 2026

WELL.TO stock closed at C$4.27 on the TSX on 17 Mar 2026 as the market priced in WELL Health’s upcoming earnings announcement on 19 Mar 2026. Trading volume reached 1,525,635.00 shares, above the 1,339,801.00 average, signaling elevated interest. Investors will watch revenue trends, progress on the WELLSTAR spin-out, and margin guidance as potential catalysts for the next move in Canada’s digital healthcare group.